LENZ logo

LENZ Therapeutics (LENZ)

Profile

Full Name

LENZ Therapeutics, Inc.

Ticker Symbol

LENZ

Exchange

NASDAQ

Country

United States

IPO

March 22, 2024

Indexes

Not included

Employees

6

Key Details

Price

$25.62

Market Cap

$705.65M(Small cap)

Last Dividend

$1.03

TTM Dividend Yield

4.02%

Annual Revenue

-

Annual EPS

-$2.34(+14.60% YoY)

PE Ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Mar 20, 25 Citigroup
Buy
Nov 7, 24 HC Wainwright & Co.
Buy
Sep 27, 24 Raymond James
Outperform
Aug 15, 24 Piper Sandler
Overweight
Aug 15, 24 HC Wainwright & Co.
Buy
Aug 12, 24 HC Wainwright & Co.
Buy
Apr 15, 24 William Blair
Outperform
Apr 15, 24 Leerink Partners
Outperform
Apr 10, 24 Citigroup
Buy
Mar 27, 24 Piper Sandler
Overweight

Institutional Ownership

  • What is the ticker symbol for LENZ Therapeutics?
  • Does LENZ Therapeutics pay dividends?
  • What sector is LENZ Therapeutics in?
  • What industry is LENZ Therapeutics in?
  • What country is LENZ Therapeutics based in?
  • When did LENZ Therapeutics go public?
  • Is LENZ Therapeutics in the S&P 500?
  • Is LENZ Therapeutics in the NASDAQ 100?
  • Is LENZ Therapeutics in the Dow Jones?
  • When was LENZ Therapeutics's last earnings report?
  • When does LENZ Therapeutics report earnings?
  • Should I buy LENZ Therapeutics stock now?

What is the ticker symbol for LENZ Therapeutics?

The ticker symbol for LENZ Therapeutics is NASDAQ:LENZ

Does LENZ Therapeutics pay dividends?

Yes, LENZ Therapeutics pays dividends. The last payment was $1.03, with an ex-dividend date on March 22, 2024

What sector is LENZ Therapeutics in?

LENZ Therapeutics is in the Healthcare sector

What industry is LENZ Therapeutics in?

LENZ Therapeutics is in the Biotechnology industry

What country is LENZ Therapeutics based in?

LENZ Therapeutics is headquartered in United States

When did LENZ Therapeutics go public?

LENZ Therapeutics's initial public offering (IPO) was on March 22, 2024

Is LENZ Therapeutics in the S&P 500?

No, LENZ Therapeutics is not included in the S&P 500 index

Is LENZ Therapeutics in the NASDAQ 100?

No, LENZ Therapeutics is not included in the NASDAQ 100 index

Is LENZ Therapeutics in the Dow Jones?

No, LENZ Therapeutics is not included in the Dow Jones index

When was LENZ Therapeutics's last earnings report?

LENZ Therapeutics's most recent earnings report was on Mar 19, 2025

When does LENZ Therapeutics report earnings?

The next expected earnings date for LENZ Therapeutics is May 30, 2025

Should I buy LENZ Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page